Skip to main content

Dedicated to improving the lives of individuals with eosinophilic gastrointestinal disorders

 

 

 

CEGIR Mission Statement

The Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) is dedicated to improving the lives of individuals with eosinophilic gastrointestinal disorders through innovative research, clinical expertise and education via collaborations between scientists, health care providers, patients, and professional organizations.

Dr. Marc Rothenberg, MD, PhD poses with a CEGIR patient who wears a mask that reads, "Hero"

Join One of Our Research Studies

Participants make it possible for researchers to find new treatments, speed diagnosis, and improve the lives of those affected by rare diseases

Find a Study

Rare Research Report: January 2025

Each month, we share summaries of recent Rare Diseases Clinical Research Network (RDCRN) grant-funded publications.

Rare Research Report logo

Join the RDCRN for FDA-NIH Rare Disease Day, February 27-28, 2025

Don’t miss the in-person and virtual celebration of FDA-NIH Rare Disease Day on February 27-28, 2025.

FDA-NIH Rare Disease Day. February 27-28, 2025

Rare Research Report: December 2024

Each month, we share summaries of recent Rare Diseases Clinical Research Network (RDCRN) grant-funded publications.

Rare Research Report logo

Get to Know Us

Learn more about CEGIR, one of 20 consortia funded by the National Institutes of Health through the Rare Diseases Clinical Research Network. Together, we are working to better understand how Eosinophilic Gastrointestinal Diseases progress and to develop improved approaches for diagnosis and treatment.
Watch Now

CEGIR Updates

Newsletter of the Consortium of Eosinophilic Gastrointestinal Disease Researchers

RDCRN Funds CEGIR for a 2nd Cycle, Welcome to New Training Scholars, and More

Learn More
Newsletter Image